A 43 year old woman on Triptorelin presenting with Pseudotumor Cerebri

Journal of Medical Case Reports, 05/11/2012

The authors recommend that the high risk patients (female overweight patients of reproductive age group) who are using any GnRH analogue should be periodically monitored for the possible development of BIH.

Print Article Summary Cat 2 CME Report